ARAYACCURAY INC
- PR Newswire
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2026, ended June 30, 2026. Key Highlights The... ...
- PR Newswire
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
MADISON, Wis., Aug. 12, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) announced two key leadership appointments intended to improve operational execution and profitability, deliver increased customer value, ...
- PR Newswire
Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2026, ended June 30, 2026, during a... ...
- PR Newswire
Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation
Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced a plan incorporating... ...
- Analyst Upgrades
BTIG Suspends Neutral Rating on Accuray
BTIG suspends Neutral rating on Accuray . ...
- PR Newswire
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new... ...
- PR Newswire
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic... ...
- Analyst Upgrades
Jefferies Downgrades Accuray to Hold, Lowers Price Target to $0.35
Jefferies analyst Young Li downgrades Accuray from Buy to Hold and lowers the price target from $3.5 to $0.35. ...
- Analyst Upgrades
This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Wall Street analysts changed outlook on top names, downgraded Amplitude Inc, Accuray Inc, Angi Inc, PayPal Holdings, and Criteo S.A. See analyst ratings. ...
- Analyst Upgrades
This Aprea Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday
Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Analysts view APRE, SRFM, CNH stocks. ...
- Analyst Upgrades
BTIG Downgrades Accuray to Neutral
BTIG analyst Marie Thibault downgrades Accuray from Buy to Neutral. ...
- PR Newswire
Accuray Reports Fiscal 2026 Third Quarter Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026. Key Highlights Transformation plan... ...
- PR Newswire
Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a... ...
- PR Newswire
Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul... ...
- Analyst Upgrades
BTIG Maintains Buy on Accuray, Lowers Price Target to $2
BTIG analyst Marie Thibault maintains Accuray with a Buy and lowers the price target from $4 to $2. ...
- PR Newswire
Accuray Reports Fiscal 2026 Second Quarter Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025. Key Highlights On December 15,... ...
- PR Newswire
Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2026, ended December 31, 2025, during a... ...
- PR Newswire
Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth
Accuray Incorporated (NASDAQ: ARAY) today announced the first phase of its comprehensive strategic, operational, and organizational transformation... ...
- Analyst Upgrades
BTIG Maintains Buy on Accuray, Lowers Price Target to $4
BTIG analyst Marie Thibault maintains Accuray with a Buy and lowers the price target from $5 to $4. ...
- PR Newswire
Accuray Reports Fiscal 2026 First Quarter Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2025. Key Highlights On October 20,... ...
- PR Newswire
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Stephen La Neve, the company's... ...
- PR Newswire
Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a... ...
- PR Newswire
Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth
Accuray Incorporated (NASDAQ: ARAY) today announced it is engaging in a significant organizational, strategic, and operational transformation. To... ...
- PR Newswire
Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System
Accuray Incorporated (NASDAQ: ARAY) announced today that 5D Clinics has treated the first patients in the city of Melbourne, Australia, using the... ...
- SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - ACCURAY INC (0001138723) (Subject)
[Amend] Statement of Beneficial Ownership by Certain Investors ...